Skip directly to search
Skip directly to A to Z list
Skip directly to navigation
Skip directly to page options
Skip directly to site content
Start of Search Controls
Search Form Controls
Search The CDC
submit
CDC A-Z Index
MENU
CDC A-Z
SEARCH
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Search Form Controls
Search The CDC
submit
CDC A-Z Index
Public Health Genomics and Precision Health Knowledge Base (v9.0)
PHGKB
About
Public Health Genomics Branch
PHGKB Weekly Horizon Scan
Genomics Precision Health Scan
Advanced Molecular Detection Clips
Non-Genomics Precision Health Scan
CDC-authored Publications Scan
Specialized PHGKB
Cancer PHGKB
Diabetes PHGKB
Economic Evaluation PHGKB
Environmental Health PHGKB
Family Health History PHGKB
Health Equity PHGKB
HLBS-PopOmics
Infectious Diseases PHGKB
Implementation Science PHGKB
Neurological Disorders PHGKB
Pharmacogenomics PHGKB
Primary Immune Deficiency Diseases PHGKB
Rare Diseases PHGKB
Reproductive and Child Health PHGKB
All Databases
COVID-19 GPH (47382)
CDC/NIH Web Information Database (32170)
CDC-Authored Genomics and Precision Health Publications Database (5894)
Precision Health Database (63623)
Tier-Classified Guidelines Database (533)
Pathogen Advanced Molecular Detection Database (26729)
All of Us Reports and Publications Database (656)
Human Genome Epidemiology
Human Genome Epidemiology Literature Finder (226219)
Epigenetic Epidemiology Publications Database (22714)
Release Note
Contact Us
Precision Health Database
Precision Health Database|Search|Public Health Genomics and Precision Health Knowledge Base (PHGKB)
Last data update: Apr 18, 2024
. (Total: 63623 Documents since 2012)
All
Cancer
Diabetes
Economic
Equity
Environmental
FHH
HLBS
ID
Implementation
ND
PGx
PI
Rare
RCH
dataset
All
GPH
Non-GPH
Filtered By
:
Select to fine-tune your search
Disease
Gene
Product Type
Category
Year
Previous
Records 1 - 30 (of 33 Records)
Next
Query Trace:
Brca[original query]>>Guidelines Related[Product Type]
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology.
Miglietta Federica et al. Breast (Edinburgh, Scotland) 2022 66293-304
Similar articles in PubMed
Ovarian cancer risk management in BRCA-mutation carriers: A comparison of six international and national guidelines.
Matan Liat S et al. European journal of obstetrics, gynecology, and reproductive biology 2022 278166-171
Similar articles in PubMed
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies.
Russo A et al. ESMO open 2022 7(3) 100459
Similar articles in PubMed
Practice guidelines for BRCA1/2 tumour testing in ovarian cancer.
Grafodatskaya Daria et al. Journal of medical genetics 2022
Similar articles in PubMed
European Experts Consensus: BRCA/Homologous Recombination Deficiency Testing in First-Line Ovarian Cancer.
Vergote I et al. Annals of oncology : official journal of the European Society for Medical Oncology 2021
Similar articles in PubMed
Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1/2 mutations.
Smith Maria J et al. American journal of obstetrics and gynecology 2021
Similar articles in PubMed
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA 1/2 variants in ovarian cancer in the United Kingdom.
Sundar Sudha et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2021 Jan
Similar articles in PubMed
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement.
et al. American family physician 2020 Feb 101(4) 233-238
Similar articles in PubMed
Points to consider: is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG).
Pal Tuya et al. Genetics in medicine : official journal of the American College of Medical Genetics 2019 Dec
Similar articles in PubMed
Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH).
Palacios J et al. Virchows Archiv : an international journal of pathology 2019 Dec
Similar articles in PubMed
Position Statement on Direct to Consumer Genetic Testing
Royal College of General Practitioners, November 2019
No. 344-Opportunistic Salpingectomy and Other Methods of Risk Reduction for Ovarian/Fallopian Tube/Peritoneal Cancer in the General Population.
Salvador Shannon et al. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2017 Jun 39(6) 480-493
Similar articles in PubMed
US Preventive Services Task Force Breast Cancer Recommendation Statement on Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer.
Newman Lisa et al. JAMA surgery 2019 Aug
Similar articles in PubMed
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
, et al. JAMA 2019 0 0. (7) 652-665
Similar articles in PubMed
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36715)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): BRCA1 and BRCA2 Genetic Testing (L36499)
The U.S. Centers for Medicare & Medicaid Services
Local Coverage Determination (LCD): Biomarkers Overview (L35062)
The U.S. Centers for Medicare & Medicaid Services
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Gori Stefania et al. Critical reviews in oncology/hematology 2019 May 14067-72
Similar articles in PubMed
Draft Recommendation Statement and Draft Evidence Review: Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer
Draft Recommendation Statement BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing
USPSTF, February 2019
No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
Jacobson Michelle et al. Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 2018 Nov 40(11) 1497-1510
Similar articles in PubMed
Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer-an European consensus statement and expert recommendations.
Singer Christian F et al. European journal of cancer (Oxford, England : 1990) 2018 Nov 10654-60
Similar articles in PubMed
FDA approves olaparib for germline BRCA-mutated metastatic breast cancer
FDA, Jan 12, 2018
Practice Bulletin No. 182 Summary: Hereditary Breast and Ovarian Cancer Syndrome.
et al. Obstetrics and gynecology 2017 Sep 130(3) 657-659
Similar articles in PubMed
Committee Opinion No. 716 Summary: The Role of the Obstetrician-Gynecologist in the Early Detection of Epithelial Ovarian Cancer in Women at Average Risk.
et al. Obstetrics and gynecology 2017 Sep 130(3) 664-665
Similar articles in PubMed
Practice Bulletin No 182: Hereditary Breast and Ovarian Cancer Syndrome.
et al. Obstetrics and gynecology 2017 130(3) e110-e126
Similar articles in PubMed
Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
Paluch-Shimon S et al. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2016 Sep 27(suppl 5) v103-v110
Similar articles in PubMed
Recommendations for the implementation of BRCA testing in the care and treatment pathways of ovarian cancer patients.
Pinto Carmine et al. Future oncology (London, England) 2016 May
Similar articles in PubMed
SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
Llort G et al. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2015 Dec 17(12) 956-61
Similar articles in PubMed
Clinical Practice Guideline for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families.
Singer C F et al. Wiener klinische Wochenschrift 2015 Nov
Similar articles in PubMed
File Formats Help:
How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?
Adobe PDF file
Microsoft PowerPoint file
Microsoft Word file
Microsoft Excel file
Audio/Video file
Apple Quicktime file
RealPlayer file
Text file
Zip Archive file
SAS file
ePub file
Page last reviewed:
Feb 1, 2024
Page last updated:
Apr 18, 2024
Content source:
Public Health Genomics Branch in the Division of Blood Disorders and Public Health Genomics
,
National Center on Birth Defects and Developmental Disabilities
TOP